We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$494B
AUM Growth
-$24.5B
Cap. Flow
-$42.4B
Cap. Flow %
-8.58%
Top 10 Hldgs %
29.31%
Holding
15,899
New
1,435
Increased
5,761
Reduced
6,731
Closed
1,760

Sector Composition

Rank Sector Weight
1 Technology 3.37%
2 Healthcare 3.33%
3 Consumer Discretionary 2.43%
4 Financials 2.27%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYBT icon
10526
PUT
Stock Yards Bancorp
SYBT
$2.64B
$124K ﹤0.01%
2,500
+1,500
+150% +$70K
RAIL icon
10527
FreightCar America
RAIL
$240M
$124K ﹤0.01%
35,573
-6,822
-16% -$25.2K
BBJP icon
10528
PUT
JPMorgan BetaBuilders Japan ETF
BBJP
$19.1B
$124K ﹤0.01%
2,200
-1,800
-45% -$101K
STLN
10529
Starling Oncology, Inc. Common Stock
STLN
$658M
$124K ﹤0.01%
269,704
+239,558
+795% +$204K
CRDF icon
10530
Cardiff Oncology
CRDF
$75.3M
$124K ﹤0.01%
+55,796
New +$210K
FDMT icon
10531
CALL
4D Molecular Therapeutics
FDMT
$630M
$124K ﹤0.01%
5,900
-67,400
-92% -$1.69M
AFMD
10532
CALL
DELISTED
Affimed
AFMD
$124K ﹤0.01%
22,710
+21,680
+2,105% +$122K
PHLT
10533
DELISTED
Performant Healthcare Inc
PHLT
$124K ﹤0.01%
42,629
-27,238
-39% -$78.2K
PGEN icon
10534
CALL
Precigen
PGEN
$2.19B
$124K ﹤0.01%
78,200
+16,800
+27% +$24.4K
AVO icon
10535
PUT
Mission Produce
AVO
$1.15B
$124K ﹤0.01%
12,500
-1,500
-11% -$17.1K
PRA
10536
PUT
DELISTED
ProAssurance
PRA
$123K ﹤0.01%
10,100
-34,800
-78% -$472K
CNNE icon
10537
PUT
Cannae Holdings
CNNE
$643M
$123K ﹤0.01%
6,800
-500
-7% -$9.71K
WVE icon
10538
Wave Life Sciences
WVE
$1.06B
$123K ﹤0.01%
24,716
-59,913
-71% -$342K
PZA icon
10539
CALL
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.26B
$123K ﹤0.01%
5,200
+1,700
+49% +$40.2K
MCHB
10540
Mechanics Bancorp
MCHB
$3.79B
$123K ﹤0.01%
10,785
+3,253
+43% +$35.7K
TSLR icon
10541
PUT
GraniteShares 2x Long TSLA Daily ETF
TSLR
$74.7M
$123K ﹤0.01%
+8,800
New +$100K
SMHI icon
10542
CALL
SEACOR Marine Holdings
SMHI
$265M
$123K ﹤0.01%
9,100
+4,200
+86% +$54.7K
NMIH icon
10543
CALL
NMI Holdings
NMIH
$3.42B
$123K ﹤0.01%
3,600
-12,500
-78% -$402K
IART icon
10544
PUT
Integra LifeSciences
IART
$1.42B
$122K ﹤0.01%
4,200
+1,600
+62% +$47.5K
NGVT icon
10545
PUT
Ingevity
NGVT
$2.62B
$122K ﹤0.01%
2,800
-800
-22% -$38.7K
TMP icon
10546
PUT
Tompkins Financial
TMP
$1.45B
$122K ﹤0.01%
2,500
-600
-19% -$27.6K
DIV icon
10547
Global X SuperDividend US ETF
DIV
$786M
$122K ﹤0.01%
7,086
+2,418
+52% +$41.6K
USNA icon
10548
PUT
Usana Health Sciences
USNA
$247M
$122K ﹤0.01%
2,700
-7,100
-72% -$327K
RPC
10549
CALL
Ridgepost Capital
RPC
$960M
$122K ﹤0.01%
14,400
+11,600
+414% +$92.6K
FWONA icon
10550
PUT
Liberty Media Series A
FWONA
$23.8B
$122K ﹤0.01%
1,900
-2,000
-51% -$127K

Similar funds

Citadel Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Citadel Advisors held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Carrier Global worth $140M.

  • Citadel Advisors's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
  • Citadel Advisors added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
  • Citadel Advisors's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
  • Citadel Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
  • Citadel Advisors's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
  • Citadel Advisors opened 1,435 new positions and closed 1,760 in Q2 2024.
  • Citadel Advisors's portfolio value fell 4.7% quarter-over-quarter to $494B.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.